← Back
$IKT All transactions

Inhibikase Therapeutics, Inc.

A

$ Value

$0

Shares

134,427

Price

$0

Filed

Jul 2

Insider

Name

Aurentz Vincent

Title

CIK

0001657494

Roles

Director

Transaction Details

Transaction Date

2025-02-21

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

134,427

Footnotes

The Reporting Person's Form 4 filed with the SEC on February 25, 2025 inadvertently reported an incorrect exercise price with respect to the stock option award originally granted on February 21, 2025. This amendment is being filed solely to correct the exercise price. | The options will vest and become exercisable in two substantially equal installments on the first and second anniversaries of February 21, 2025, subject to the Reporting Person's continued services through such date.

Filing Info

Accession No.

0000950170-25-093440

Form Type

4/A

Issuer CIK

0001750149

Aurentz Vincent's History

Date Ticker Type Value
2025-06-30 IKT A $0
2025-02-21 IKT A $0

Other Insiders at IKT (90d)

No other insider activity at this issuer in the last 90 days.